Live Breaking News & Updates on Wenjia Feng

Stay updated with breaking news from Wenjia feng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Liquid biopsy could guide therapy for colorectal cancer


A liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread beyond the original tumor, a new study shows.
This kind of biopsy can detect lingering disease and could serve as a guide for deciding whether a patient should undergo further treatments due to some tumor cells evading an initial attempt to eradicate the cancer.
The findings appear in the
While the Food and Drug Administration has approved a few liquid biopsies, mostly for lung, breast, ovarian, and prostate cancers, it has not approved any for colorectal cancer. ....

United States , Wenjia Feng , Nadja Pejovic , Aadela Chaudhuri , Bruna Pellini , David Riebel Cancer Research Fund , Roche Sequencing Solutions , Siteman Cancer Center At Barnes , American Surgical Association Foundation , Drug Administration , Moffitt Cancer Center , Washington University School Of Medicine , Cancer Research Foundation , Washington University , Society Of Surgical Oncology , American Cancer Society , Clinical Oncology Precision , Washington University School , Siteman Cancer Center , Barnes Jewish Hospital , National Cancer Institute , National Institutes , Surgical Oncology , Sidney Kimmel Translational Science Scholar Award , ஒன்றுபட்டது மாநிலங்களில் , ரோச் வரிசைப்படுத்துதல் தீர்வுகள் ,

Liquid biopsy for colorectal cancer could guide therapy for tumors | The Source | Washington University in St. Louis


Blood and urine samples identify disease that lingers after initial therapy
Researchers at Washington University School of Medicine in St. Louis have developed a liquid biopsy examining blood or urine that could help guide treatment for colorectal cancer patients. Nadja Pejovic, a visiting medical student and co-first author of a study on the liquid biopsy, works with a sample in the lab of Aadel Chaudhuri, MD, the study s senior author. (Photo: Peter Harris)
February 12, 2021
SHARE
A new study from Washington University School of Medicine in St. Louis demonstrates that a liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread beyond the original tumor. Such a biopsy can detect lingering disease and could serve as a guide for deciding whether a patient should undergo further treatments due to some tumor cells evading an initial attempt to eradicate the cancer. ....

United States , Wenjia Feng , Nadja Pejovic , Aadela Chaudhuri , Bruna Pellini , Washington University , American Society Of Clinical Oncology , Siteman Cancer Center At Barnes , Drug Administration , Moffitt Cancer Center , Washington University School Of Medicine , Washington University School , Clinical Oncology Precision , American Society , Siteman Cancer Center , Barnes Jewish Hospital , ஒன்றுபட்டது மாநிலங்களில் , வாஷிங்டன் பல்கலைக்கழகம் , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , மாஃபிட் புற்றுநோய் மையம் , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி , மருத்துவ புற்றுநோயியல் ப்ரிஸிஶந் , அமெரிக்கன் சமூகம் , களஞ்சியங்கள் நகை மருத்துவமனை ,